Open AccessFactors Associated With Children Diagnosed With Attention-Deficit/Hyperactivity Disorder and 30-Day Follow-up Care With Practitioners Among Medicaid Recipients in Georgia
Author(s) -
Henry H. Yin,
Brendan Ibe,
Tiffany L Parr,
Seema Csukas,
Bobby Jones,
Sandra Thompson
Publication year - 2021
Publication title -
quality management in health care
Language(s) - English
Resource type - Journals
eISSN - 1550-5154
pISSN - 1063-8628
DOI - 10.1097/qmh.0000000000000345
Subject(s) - medicaid , medicine , psychosocial , residence , odds ratio , attention deficit hyperactivity disorder , medical prescription , emergency department , confidence interval , pediatrics , specialty , psychiatry , family medicine , demography , health care , sociology , economics , pharmacology , economic growth
It is important that children prescribed attention-deficit/hyperactivity disorder (ADHD) medication get timely follow-up care. In 2018, only 44% of US Medicaid recipients attended a follow-up visit within 30 days of their first ADHD prescription. The objective of this study was to identify the member and practitioner-related predictors that were associated with children who were diagnosed with ADHD and had a follow-up visit within 30 days (initiation phase) of their first prescription of ADHD medication (Index Prescription Start Date, or IPSD).